Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: A nationwide population-based study

Annals of the Rheumatic Diseases

Volumn 72, Issue 5, 2013, Pages 694-700

  Trifirò, Gianluca ^a,b   Morabito, Paolo ^a   Cavagna, Lorenzo ^c   Ferrajolo, Carmen ^b,d   Pecchioli, Serena ^e   Simonetti, Monica ^e   Bianchini, Elisa ^e   Medea, Gerardo ^f   Cricelli, Claudio ^f   Caputi, Achille P ^a   Mazzaglia, Giampiero ^e  

^a UNIVERSITY OF MESSINA   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PAVIA   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e Italian College of General Practitioners   (Italy)

^f Italian College of General Practitioners   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; URIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GOUT; HUMAN; HYPERURICEMIA; INCIDENCE; ITALY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; SEX DIFFERENCE; TREND STUDY; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; GOUT; HUMANS; HYPERURICEMIA; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RECURRENCE; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84875962011     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-201254     Document Type: Article

References (44)

1. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther 2010;12:223.
2. Cea Soriano L, Rothenbacher D, Choi HK, et al. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 2011;13:R39.
3. Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia. Am Fam Physician 1999;59:925-34. (Pubitemid 29108611)
4. Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care 2005;11(15 Suppl):S435-42; quiz S465-8. (Pubitemid 41722200)
5. Eggebeen AT. Gout: an update. Am Fam Physician 2007;76:801-8.
6. Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003;349:1647-55.
7. Hosomi A, Nakanishi T, Fujita T, et al. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS ONE 2012;7:e30456.
8. Hollis-Moffatt JE, Gow PJ, Harrison AA, et al. The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity. Arthritis Res Ther 2011;13:R85.
9. Hollis-Moffatt JE, Xu X, Dalbeth N, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian casecontrol sample sets. Arthritis Rheum 2009;60:3485-92.
10. Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet 2010;19:4813-9.
11. Simmonds HA, McBride MB, Hatfield PJ, et al. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994;33:932-7. (Pubitemid 24324808)
12. Sica DA, Carter B, Cushman W, et al. Thiazide and loop diuretics. J Clin Hypertens (Greenwich) 2011;13:639-43.
13. Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Semin Nephrol 2011;31:410-19.
14. Larina VN, Bart BIa, Brodski1 MS. (Hyperuricemia in chronic heart failure). Kardiologiia 2011;51:68-73.
15. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11:229.
16. Wallace KL, Riedel AA, Joseph-Ridge N, et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7. (Pubitemid 39006641)
17. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999;200:1-203.
18. Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-14. (Pubitemid 39066263)
19. Klemp P, Stansfield SA, Castle B, et al. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-6. (Pubitemid 27060568)
20. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136-41.
21. Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008;67:960-6. (Pubitemid 351956658)
22. Miao Z, Li C, Chen Y, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008;35:1859-64.
23. Nan H, Qiao Q, Dong Y, et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006;33:1346-50. (Pubitemid 44025149)
24. Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003;25:254-7. (Pubitemid 37237080)
25. Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005;23:2093-100. (Pubitemid 41830406)
26. Khan M, Khan RA, Islam F, et al. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients. Pak J Pharm Sci 2011;24:583-7.
27. Hamada T, Hisatome I, Shigemasa C. (Drug-induced hyperuricemia). Nippon Rinsho 2003;61 Suppl 1:333-7.
28. Mazali FC, Mazzali M. Uric acid and transplantation. Semin Nephrol 2011;31:466-71.
29. Borges RL, Hirota AH, Quinto BM, et al. Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J Clin Hypertens (Greenwich) 2009;11:253-9.
30. Chuang SY, Lee SC, Hsieh YT, et al. Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 2011;20:301-8.
31. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
32. Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72. (Pubitemid 40197509)
33. Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the Health Professionals' Follow-up Study. Arch Intern Med 2005;165:742-8. (Pubitemid 40569426)
34. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103. (Pubitemid 38298989)
35. Daniel CR, Cross AJ, Koebnick C, et al. Trends in meat consumption in the USA. Public Health Nutr 2011;14:575-83.
36. Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81. (Pubitemid 38496489)
37. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008;336:309-12. (Pubitemid 351278368)
38. Choi JW, Ford ES, Gao X, et al. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008;59:109-16. (Pubitemid 351171885)
39. Winnard D, Wright C, Taylor WJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology 2012;51:901-9.
40. Azzini E, Polito A, Fumagalli A, et al. Mediterranean diet effect: an Italian picture. Nutr J 2011;10:125.
41. Chrysohoou C, Skoumas J, Pitsavos C, et al. Long-term adherence to the Mediterranean diet reduces the prevalence of hyperuricaemia in elderly individuals, without known cardiovascular disease: the Ikaria study. Maturitas 2011;70: 58-64.
42. Gibson T. Hyperuricemia, gout and the kidney. Curr Opin Rheumatol 2012;24: 127-31.
43. Lin HY, Rocher LL, McQuillan MA, et al. Cyclosporine-induced hyperuricemia and gout. N Engl J Med 1989;321:287-92. (Pubitemid 19193803)
44. Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1312-24. (Pubitemid 44620440)